Biocon Biologics Archives - Page 5 of 9 - Express Pharma

Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion

Kiran Mazumdar-Shaw Elected as Fellow of Royal Society of Edinburgh

Biocon Biologics to acquire Viatris’ biosimilars assets for up to $3.335 billion

Biocon’s consolidated Q3FY22 revenue grows by 18 per cent YoY to Rs 2,223 crores

Viatris wins US court decisions on Sanofi appeals for Lantus device patents

Biocon Biologics initiates clinical study for Itolizumab in Lupus Nephritis

Biocon Biologics and Viatris launch interchangeable Semglee

Biocon Biologics and Viatris’s Semglee preferred on Express Scripts’ largest formulary in US

Biocon Biologics-SII alliance should balance business and public health

Biocon Biologics insulin manufacturing facility in Malaysia completes USFDA (PAI) inspection